Abstract
Recent evidence suggests that chemotherapy (CT) efficacy relies in part on the capacity of chemotherapeutic agents to interact with the immune system. CT can induce various tumor cell death modalities processed by immune cells, resulting in their activation and induction of antitumor immunity. Long-term effects of conventional CT may be attributed to the stimulation of immunological responses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
